Neurocrine UK Limited clinical trials

Formerly part of Neurocrine Biosciences, Jan 21, 2026 · source ↗

The registry lists 18 studies whose lead sponsor is Neurocrine UK Limited. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 2, 2026.

Studies

Recruiting first, then most recently updated. Showing 18 of 18. All Neurocrine Biosciences studies →

• Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal HyperplasiaCompletedNCT05063994Phase 3

  Sponsor listed in the registry: Neurocrine UK Limited · First submitted before Neurocrine UK Limited left Neurocrine Biosciences

• A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAHCompletedNCT03062280Phase 3

  Sponsor listed in the registry: Neurocrine UK Limited · First submitted before Neurocrine UK Limited left Neurocrine Biosciences

• An Investigational Study of HydrocortisoneCompletedNCT01960530Phase 1

  Sponsor listed in the registry: Neurocrine UK Limited · First submitted before Neurocrine UK Limited left Neurocrine Biosciences

• Extension Study for Patients Entered Into Study Infacort 003CompletedNCT02733367Phase 3

  Sponsor listed in the registry: Neurocrine UK Limited · First submitted before Neurocrine UK Limited left Neurocrine Biosciences

• Comparison of Pharmacokinetics of Infacort® Versus Immediate-release HydrocortisoneCompletedNCT02777268Phase 1

  Sponsor listed in the registry: Neurocrine UK Limited · First submitted before Neurocrine UK Limited left Neurocrine Biosciences

• Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAHCompletedNCT01735617Phase 2

  Sponsor listed in the registry: Neurocrine UK Limited · First submitted before Neurocrine UK Limited left Neurocrine Biosciences

• Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal HyperplasiaCompletedNCT02716818Phase 3

  Sponsor listed in the registry: Neurocrine UK Limited · First submitted before Neurocrine UK Limited left Neurocrine Biosciences

• Treatment of Adrenal Insufficiency in ChildrenCompletedNCT02720952Phase 3

  Sponsor listed in the registry: Neurocrine UK Limited · First submitted before Neurocrine UK Limited left Neurocrine Biosciences

• A Study of Chronocort® Versus Cortef ® in Healthy Adult Male SubjectsCompletedNCT03343327Phase 1

  Sponsor listed in the registry: Neurocrine UK Limited · First submitted before Neurocrine UK Limited left Neurocrine Biosciences

• An Open Label Study in Healthy Volunteers to Compare Chronocort® to HydrocortisoneCompletedNCT03019614Phase 1

  Sponsor listed in the registry: Neurocrine UK Limited · First submitted before Neurocrine UK Limited left Neurocrine Biosciences

• Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement TherapyWithdrawnNCT03532022Phase 3

  Sponsor listed in the registry: Neurocrine UK Limited · First submitted before Neurocrine UK Limited left Neurocrine Biosciences

• Bioavailability of Infacort When Administered Onto Food Compared to Direct Oral AdministrationCompletedNCT03178214Phase 1

  Sponsor listed in the registry: Neurocrine UK Limited · First submitted before Neurocrine UK Limited left Neurocrine Biosciences

• Chronocort Versus Plenadren Replacement Therapy in Adults With Adrenal InsufficiencyCompletedNCT05222152Phase 2

  Sponsor listed in the registry: Neurocrine UK Limited · First submitted before Neurocrine UK Limited left Neurocrine Biosciences

• A Study of Infacort® Versus Cortef® in Healthy Adult Male and Female SubjectsCompletedNCT03311932Phase 1

  Sponsor listed in the registry: Neurocrine UK Limited · First submitted before Neurocrine UK Limited left Neurocrine Biosciences

• Study to Compare DITEST to Testosterone Undecanoate in Adult Men With HypogonadismCompletedNCT02966652Phase 1

  Sponsor listed in the registry: Neurocrine UK Limited · First submitted before Neurocrine UK Limited left Neurocrine Biosciences

• A Two-part, Study to Compare the Pharmacokinetics and Dose Proportionality of up to 6 Chronocort FormulationsCompletedNCT03051893Phase 1

  Sponsor listed in the registry: Neurocrine UK Limited · First submitted before Neurocrine UK Limited left Neurocrine Biosciences

• Effect of Slow Release Hydrocortisone on Fed & Fasting Volunteers; Immediate Release on Fasting OnlyCompletedNCT02408068Phase 1

  Sponsor listed in the registry: Neurocrine UK Limited · First submitted before Neurocrine UK Limited left Neurocrine Biosciences

• Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal HyperplasiaCompletedNCT00519818Phase 1/2

  Sponsor listed in the registry: Neurocrine UK Limited · First submitted before Neurocrine UK Limited left Neurocrine Biosciences